Need Help?

Unmapped sequencing reads of EGAD00001007002

Bam files of unmapped sequencing reads of samples in EGAD00001007002. When utilized in combination with corresponding aligned bam files in dataset EGAD00001007002, they contain all sequencing reads of samples.

Request Access

Data access policy of PSCCE study

Data Access Agreement Version 1.2.20210502 This Data Access Agreement governs the terms of access to controlled datasets generated by Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences. In signing this agreement, you agree to be bound by the terms and conditions of access set out therein. Definitions Data Provider: Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences. Data: ______________________________________(please type in the Study/Dataset/Data title and ID for the Data applied) User: An applicant, having signed this Data Access Agreement, whose User Institution has cosigned this Data Access Agreement, both of them having received acknowledgement of its acceptance. Any person listed as a co-author of the papers or publications using the Data would be considered a User and should sign this Data Access Agreement. User Institution: Institution at which the User is employed, affiliated or enrolled. A representative of it has co-signed this Data Access Agreement with the User and received acknowledgement of its acceptance. Research Participant: An individual having contributed their personal data and human genetic resource to generate the Data. Terms and Conditions In signing this Data Access Agreement: 1. The User and the User Institution accept that the Data is protected by and subject to international laws, including but not limited to Biosecurity Law of the People’s Republic of China and the People’s Republic of China Regulations on Human Genetic Resources. The Data Provider reserves the right to request and inspect data security and management documentation to ensure the adequacy of data protection measures. 2. The User and the User Institution agree to use the Data only for the advancement of medical research. And not to use the Data for the creation of products for sales or for any commercial purpose. 3. The User and the User Institution agree to preserve, at all times, the confidentiality of the information and Data. In particular, they undertake not to use, or attempt to use the Data to compromise or otherwise infringe the confidentiality of information on research participants. 4. The User and the User Institution agree to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 5. The User and the User Institution agree not to pursue any research with the goal to identify Research Participants and not to link or combine the Data to other information or archived data in a way that would co-identify the Research Participants, even if access to the data has been formally granted to the User and the User Institution, or is freely available without restriction. 6. The User and the User Institution agree not to transfer, distribute or disclose the Data, in whole or part, or any material derived from the Data to anyone not listed in the Data Access Agreement. 7. The User and the User Institution accept that the Data Provider bears no legal responsibility for the accuracy or comprehensiveness of the Data. 8. The User and the User Institution accept that the Data Provider accepts no liability for indirect, consequential, or incidental, damages or losses arising from use of the Data. 9. The User and the User Institution agree not to make intellectual property claims on the Data and not to use intellectual property protection in ways that would prevent or block access to any element of the Data. 10. The User and the User Institution will notify the Data Provider and the Data Access Committee as soon as they become aware of a breach of the terms and conditions of this agreement. 11. This agreement shall be effective as of the date of the last party to sign below (“Effective Date”) and shall terminate two (2) years after the Effective Date, unless terminated sooner pursuant to Section 12 below. 12. The User and the User Institution accept that this Data Access Agreement may terminate immediately upon any breach of this agreement from the User and the User Institution. Either Party may terminate this Data Access Agreement upon thirty (30) days written notice for any reason. 13. In the case of Section 11 and 12, the User and the User Institution agree to destroy any Data held, including copies and backup copies. 14. The User and the User Institution agree to destroy any Data held, once it is no longer used for approved purpose. 15. The following Sections of this Data Access Agreement shall survive its expiration or termination: Sections 1-10, Sections 13-14. 16. This Data Access Agreement shall be constructed, interpreted and governed by the laws of People’s Republic of China and shall be subject to the non-exclusive jurisdiction of the courts of People’s Republic of China. For and on behalf of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences Signature of institutional representative _______________ Print name of institutional representative _______________ Date _______________ Stamp For and on behalf of the User Print name of all User(s): _______________ _______________ _______________ _______________ _______________ _______________ Signatures of all User(s): _______________ _______________ _______________ _______________ _______________ _______________ Date _______________ For and on behalf of the User Institution Name of the User Institution _______________ Signature of institutional representative _______________ Print name of institutional representative _______________ Date _______________ Stamp

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00005279009 1620586273409 189.2 MB
EGAF00005279010 1620586273409 137.8 MB
EGAF00005279011 1620586273409 118.5 MB
EGAF00005279012 1620586273409 104.7 MB
EGAF00005279013 1620586273409 138.4 MB
EGAF00005279014 1620586273409 517.4 MB
EGAF00005279015 1620586273409 134.6 MB
EGAF00005279016 1620586273409 115.4 MB
EGAF00005279017 1620586273409 55.2 MB
EGAF00005279018 1620586273409 147.6 MB
EGAF00005279019 1620586273409 114.7 MB
EGAF00005279020 1620586273409 107.5 MB
EGAF00005279021 1620586273409 87.8 MB
EGAF00005279022 1620586273409 79.8 MB
EGAF00005279023 1620586273409 146.4 MB
EGAF00005279024 1620586273409 110.6 MB
EGAF00005279025 1620586273409 134.4 MB
EGAF00005279026 1620586273409 150.5 MB
EGAF00005279027 1620586273409 126.4 MB
EGAF00005279028 1620586273409 113.7 MB
EGAF00005279029 1621242532457 121.0 MB
EGAF00005279030 1620586273409 124.7 MB
EGAF00005279031 1620586273409 73.7 MB
EGAF00005279032 1620586273409 91.4 MB
EGAF00005279033 1620586273409 127.9 MB
EGAF00005279034 1620586273409 111.3 MB
EGAF00005279035 1620586273409 94.5 MB
EGAF00005279036 1620586334585 151.2 MB
EGAF00005279037 1620586334585 171.1 MB
EGAF00005279038 1620586334585 132.2 MB
EGAF00005279039 1620586334585 135.0 MB
EGAF00005279040 1620586334585 123.3 MB
EGAF00005279041 1620586334585 155.3 MB
EGAF00005279042 1620586334585 108.4 MB
EGAF00005279043 1620586334585 113.3 MB
EGAF00005279044 1620586334585 172.6 MB
EGAF00005279045 1620586334585 167.3 MB
EGAF00005279046 1620586334585 148.0 MB
EGAF00005279047 1620586334585 266.6 MB
EGAF00005279048 1620586334585 151.0 MB
EGAF00005279049 1620586334585 128.2 MB
EGAF00005279050 1620586334585 131.7 MB
EGAF00005279051 1620586334585 230.3 MB
EGAF00005279052 1620586334585 129.1 MB
EGAF00005279053 1620586334585 143.1 MB
EGAF00005279054 1620586334585 107.2 MB
EGAF00005279055 1620586334585 151.0 MB
EGAF00005279056 1620586334585 96.7 MB
EGAF00005279057 bam 417.6 MB
EGAF00005279058 1620586334585 81.3 MB
EGAF00005279059 1620586334585 109.2 MB
EGAF00005279060 1620586334585 148.9 MB
EGAF00005279061 bam 313.6 MB
EGAF00005279062 1620586334585 95.2 MB
EGAF00005279063 1620586334585 93.6 MB
EGAF00005279064 1620586334585 107.2 MB
EGAF00005279065 1620586334585 84.0 MB
EGAF00005279066 1620586334585 140.1 MB
EGAF00005279067 1620586334585 181.3 MB
EGAF00005279068 1620586334585 280.2 MB
EGAF00005279069 1620586334585 138.2 MB
EGAF00005279070 1620586334585 126.6 MB
EGAF00005279071 1620586334585 75.6 MB
EGAF00005279072 1620586334585 98.7 MB
64 Files (9.2 GB)